Literature DB >> 19540658

Recovery of skin barrier properties after sonication in human subjects.

Jyoti Gupta1, Mark R Prausnitz.   

Abstract

The SonoPrep(R) ultrasonic skin permeation system is used clinically to increase skin permeability for rapid, noninvasive delivery of local anaesthetics. This study tested the hypothesis that sonication can generate a long-lived increase of skin permeability for continuous transdermal drug delivery and diagnostic metabolite extraction. To accomplish this, the volar forearm skin of ten healthy adult subjects was sonicated. As a surrogate measure of skin permeability, skin electrical impedance was measured at occluded and nonoccluded sites every hour over a period of 48 h. Sonication dramatically increased skin permeability, as demonstrated by a large drop in skin impedance. Under occlusion, sonicated skin remained highly permeable during the entire 42-h period of occlusion, which was followed by an immediate decrease in permeability upon removal of occlusion. Without occlusion, sonicated skin retained elevated permeability throughout the 48-h experiment, but regained its barrier function more quickly. Therefore, sonication can increase skin permeability for prolonged periods of time, especially under the effect of occlusion, and has potential to facilitate continuous transdermal drug delivery and diagnostic metabolite extraction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540658      PMCID: PMC2713370          DOI: 10.1016/j.ultrasmedbio.2009.04.001

Source DB:  PubMed          Journal:  Ultrasound Med Biol        ISSN: 0301-5629            Impact factor:   2.998


  12 in total

1.  Theoretical description of transdermal transport of hydrophilic permeants: application to low-frequency sonophoresis.

Authors:  H Tang; S Mitragotri; D Blankschtein; R Langer
Journal:  J Pharm Sci       Date:  2001-05       Impact factor: 3.534

2.  Transdermal monitoring of glucose and other analytes using ultrasound.

Authors:  J Kost; S Mitragotri; R A Gabbay; M Pishko; R Langer
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

Review 3.  Current status and future potential of transdermal drug delivery.

Authors:  Mark R Prausnitz; Samir Mitragotri; Robert Langer
Journal:  Nat Rev Drug Discov       Date:  2004-02       Impact factor: 84.694

Review 4.  Low-frequency sonophoresis: a review.

Authors:  Samir Mitragotri; Joseph Kost
Journal:  Adv Drug Deliv Rev       Date:  2004-03-27       Impact factor: 15.470

5.  Relationships between skin's electrical impedance and permeability in the presence of chemical enhancers.

Authors:  Pankaj Karande; Amit Jain; Samir Mitragotri
Journal:  J Control Release       Date:  2005-11-28       Impact factor: 9.776

6.  Defects generated in human stratum corneum specimens by ultrasound.

Authors:  J Wu; J Chappelow; J Yang; L Weimann
Journal:  Ultrasound Med Biol       Date:  1998-06       Impact factor: 2.998

7.  Low-frequency ultrasound as a transcutaneous immunization adjuvant.

Authors:  Ahmet Tezel; Sumit Paliwal; Zancong Shen; Samir Mitragotri
Journal:  Vaccine       Date:  2005-03-16       Impact factor: 3.641

8.  Description of transdermal transport of hydrophilic solutes during low-frequency sonophoresis based on a modified porous pathway model.

Authors:  Ahmet Tezel; Ashley Sens; Samir Mitragotri
Journal:  J Pharm Sci       Date:  2003-02       Impact factor: 3.534

9.  Transepidermal water loss: the signal for recovery of barrier structure and function.

Authors:  G Grubauer; P M Elias; K R Feingold
Journal:  J Lipid Res       Date:  1989-03       Impact factor: 5.922

10.  Rapid onset of cutaneous anesthesia with EMLA cream after pretreatment with a new ultrasound-emitting device.

Authors:  Nathaniel P Katz; David E Shapiro; Timothy E Herrmann; Joseph Kost; Linda M Custer
Journal:  Anesth Analg       Date:  2004-02       Impact factor: 5.108

View more
  8 in total

1.  Recovery of skin barrier after stratum corneum removal by microdermabrasion.

Authors:  Samantha Andrews; Jeong Woo Lee; Mark Prausnitz
Journal:  AAPS PharmSciTech       Date:  2011-10-19       Impact factor: 3.246

2.  Enhancing the transdermal delivery of rigid nanoparticles using the simultaneous application of ultrasound and sodium lauryl sulfate.

Authors:  Renata F V Lopez; Jennifer E Seto; Daniel Blankschtein; Robert Langer
Journal:  Biomaterials       Date:  2010-10-23       Impact factor: 12.479

3.  Effects of ultrasound and sodium lauryl sulfate on the transdermal delivery of hydrophilic permeants: Comparative in vitro studies with full-thickness and split-thickness pig and human skin.

Authors:  Jennifer E Seto; Baris E Polat; Renata F V Lopez; Daniel Blankschtein; Robert Langer
Journal:  J Control Release       Date:  2010-03-25       Impact factor: 9.776

4.  Dissolving microneedle patch for transdermal delivery of human growth hormone.

Authors:  Jeong Woo Lee; Seong-O Choi; Eric I Felner; Mark R Prausnitz
Journal:  Small       Date:  2011-01-04       Impact factor: 13.281

Review 5.  Low-frequency sonophoresis: application to the transdermal delivery of macromolecules and hydrophilic drugs.

Authors:  Baris E Polat; Daniel Blankschtein; Robert Langer
Journal:  Expert Opin Drug Deliv       Date:  2010-12       Impact factor: 6.648

6.  Relations between acoustic cavitation and skin resistance during intermediate- and high-frequency sonophoresis.

Authors:  Kyle T Rich; Cameron L Hoerig; Marepalli B Rao; T Douglas Mast
Journal:  J Control Release       Date:  2014-08-15       Impact factor: 9.776

7.  Diclofenac delays micropore closure following microneedle treatment in human subjects.

Authors:  Nicole K Brogden; Mikolaj Milewski; Priyanka Ghosh; Lucia Hardi; Leslie J Crofford; Audra L Stinchcomb
Journal:  J Control Release       Date:  2012-08-21       Impact factor: 9.776

8.  Sonophoresis Using Ultrasound Contrast Agents: Dependence on Concentration.

Authors:  Donghee Park; Gillsoo Song; Yongjun Jo; Jongho Won; Taeyoon Son; Ohrum Cha; Jinho Kim; Byungjo Jung; Hyunjin Park; Chul-Woo Kim; Jongbum Seo
Journal:  PLoS One       Date:  2016-06-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.